No support found for dual antiplatelet therapy after cardiac bypass surgery over aspirin alone

Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers. Today, dual antiplatelet therapy is recommended in international treatment guidelines after heart bypass surgery for acute coronary artery disease. The current study compares two different antithrombotic, i.e., blood-thinning, treatments. One is single antiplatelet therapy with acetylsalicylic acid (Aspirin) alone, the other is dual antiplatelet therapy with acetylsalicylic acid and ticagrelor (Brilique). "There is no doubt that this patient group needs antiplatelet therapy. However, it has so far been unclear...